

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to kinetochore (GO:0034501) | 6.13806037 |
| 2 | protein localization to chromosome, centromeric region (GO:0071459) | 5.20631502 |
| 3 | formation of translation preinitiation complex (GO:0001731) | 4.45467171 |
| 4 | maturation of SSU-rRNA (GO:0030490) | 4.41943039 |
| 5 | DNA deamination (GO:0045006) | 4.16323042 |
| 6 | CENP-A containing nucleosome assembly (GO:0034080) | 4.04818440 |
| 7 | proteasome assembly (GO:0043248) | 4.02390772 |
| 8 | purine nucleobase biosynthetic process (GO:0009113) | 4.01981607 |
| 9 | nucleobase biosynthetic process (GO:0046112) | 3.99056272 |
| 10 | chromatin remodeling at centromere (GO:0031055) | 3.87112347 |
| 11 | establishment of integrated proviral latency (GO:0075713) | 3.83940354 |
| 12 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.83615113 |
| 13 | termination of RNA polymerase III transcription (GO:0006386) | 3.83615113 |
| 14 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.77143643 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 3.76319926 |
| 16 | viral mRNA export from host cell nucleus (GO:0046784) | 3.75563455 |
| 17 | mitotic metaphase plate congression (GO:0007080) | 3.74389205 |
| 18 | mitotic chromosome condensation (GO:0007076) | 3.70498235 |
| 19 | regulation of mitochondrial translation (GO:0070129) | 3.67680829 |
| 20 | 7-methylguanosine RNA capping (GO:0009452) | 3.62830895 |
| 21 | RNA capping (GO:0036260) | 3.62830895 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 3.61422356 |
| 23 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.60926058 |
| 24 | DNA strand elongation (GO:0022616) | 3.60007655 |
| 25 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.59379071 |
| 26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.58463432 |
| 27 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.58034899 |
| 28 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.57402576 |
| 29 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.55789958 |
| 30 | DNA replication checkpoint (GO:0000076) | 3.55290333 |
| 31 | histone exchange (GO:0043486) | 3.51060929 |
| 32 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.50078758 |
| 33 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.47733476 |
| 34 | protein deneddylation (GO:0000338) | 3.47371193 |
| 35 | cullin deneddylation (GO:0010388) | 3.46833590 |
| 36 | DNA replication initiation (GO:0006270) | 3.44797565 |
| 37 | establishment of chromosome localization (GO:0051303) | 3.44538702 |
| 38 | establishment of viral latency (GO:0019043) | 3.43890366 |
| 39 | 7-methylguanosine mRNA capping (GO:0006370) | 3.43764083 |
| 40 | ribosome assembly (GO:0042255) | 3.40865132 |
| 41 | spliceosomal snRNP assembly (GO:0000387) | 3.39442322 |
| 42 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.39019152 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.39019152 |
| 44 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.36776897 |
| 45 | DNA replication-independent nucleosome organization (GO:0034724) | 3.36776897 |
| 46 | viral transcription (GO:0019083) | 3.35385037 |
| 47 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.34644626 |
| 48 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.34644626 |
| 49 | translational termination (GO:0006415) | 3.33863422 |
| 50 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.33625809 |
| 51 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.33625809 |
| 52 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.33625809 |
| 53 | IMP biosynthetic process (GO:0006188) | 3.33219494 |
| 54 | nuclear pore complex assembly (GO:0051292) | 3.33137955 |
| 55 | telomere maintenance via recombination (GO:0000722) | 3.32028317 |
| 56 | ribosome biogenesis (GO:0042254) | 3.31587709 |
| 57 | respiratory chain complex IV assembly (GO:0008535) | 3.30357202 |
| 58 | ribosomal small subunit biogenesis (GO:0042274) | 3.29868327 |
| 59 | synapsis (GO:0007129) | 3.26445183 |
| 60 | protein K6-linked ubiquitination (GO:0085020) | 3.26298305 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.25984975 |
| 62 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.24011940 |
| 63 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.24011940 |
| 64 | mitotic sister chromatid cohesion (GO:0007064) | 3.23810457 |
| 65 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.21969219 |
| 66 | protein localization to chromosome (GO:0034502) | 3.21907293 |
| 67 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.20788349 |
| 68 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.20208951 |
| 69 | meiotic chromosome segregation (GO:0045132) | 3.19402681 |
| 70 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.17900118 |
| 71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.17810455 |
| 72 | translational initiation (GO:0006413) | 3.16821638 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.16651489 |
| 74 | cotranslational protein targeting to membrane (GO:0006613) | 3.15691556 |
| 75 | mitotic recombination (GO:0006312) | 3.13672424 |
| 76 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.12727526 |
| 77 | protein targeting to ER (GO:0045047) | 3.11981820 |
| 78 | positive regulation of ligase activity (GO:0051351) | 3.10181774 |
| 79 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.08720558 |
| 80 | positive regulation of chromosome segregation (GO:0051984) | 3.07794832 |
| 81 | translational elongation (GO:0006414) | 3.05879838 |
| 82 | negative regulation of chromosome segregation (GO:0051985) | 3.04688334 |
| 83 | translation (GO:0006412) | 3.04461552 |
| 84 | rRNA processing (GO:0006364) | 3.03713455 |
| 85 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.03388879 |
| 86 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.03081085 |
| 87 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.03081085 |
| 88 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.03081085 |
| 89 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.03081085 |
| 90 | negative regulation of sister chromatid segregation (GO:0033046) | 3.03081085 |
| 91 | mitotic sister chromatid segregation (GO:0000070) | 3.03009493 |
| 92 | cellular component biogenesis (GO:0044085) | 3.02394087 |
| 93 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.02054319 |
| 94 | nuclear pore organization (GO:0006999) | 3.01988258 |
| 95 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.00633401 |
| 96 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.00592185 |
| 97 | regulation of DNA endoreduplication (GO:0032875) | 3.00255490 |
| 98 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.99184343 |
| 99 | telomere maintenance via telomere lengthening (GO:0010833) | 2.98176601 |
| 100 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.97866054 |
| 101 | mitotic spindle checkpoint (GO:0071174) | 2.97805536 |
| 102 | sister chromatid segregation (GO:0000819) | 2.97684158 |
| 103 | protein localization to endoplasmic reticulum (GO:0070972) | 2.95932308 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.95809316 |
| 105 | metaphase plate congression (GO:0051310) | 2.95034221 |
| 106 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.94986290 |
| 107 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.94251523 |
| 108 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.94251523 |
| 109 | IMP metabolic process (GO:0046040) | 2.93722456 |
| 110 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.92880064 |
| 111 | histone mRNA metabolic process (GO:0008334) | 2.92810682 |
| 112 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.92452745 |
| 113 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.92452745 |
| 114 | regulation of chromosome segregation (GO:0051983) | 2.92263935 |
| 115 | regulation of ligase activity (GO:0051340) | 2.91631600 |
| 116 | mitotic spindle assembly checkpoint (GO:0007094) | 2.90608504 |
| 117 | folic acid metabolic process (GO:0046655) | 2.89960965 |
| 118 | rRNA metabolic process (GO:0016072) | 2.89419458 |
| 119 | protein targeting to mitochondrion (GO:0006626) | 2.88865698 |
| 120 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.88850372 |
| 121 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.88850372 |
| 122 | spindle assembly checkpoint (GO:0071173) | 2.85087425 |
| 123 | mitotic nuclear envelope disassembly (GO:0007077) | 2.84535274 |
| 124 | kinetochore organization (GO:0051383) | 2.84398829 |
| 125 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.83216661 |
| 126 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.83216661 |
| 127 | isotype switching (GO:0045190) | 2.83216661 |
| 128 | kinetochore assembly (GO:0051382) | 2.83063470 |
| 129 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.82001931 |
| 130 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.82001931 |
| 131 | regulation of sister chromatid segregation (GO:0033045) | 2.82001931 |
| 132 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.81911883 |
| 133 | cell cycle G1/S phase transition (GO:0044843) | 2.81911883 |
| 134 | negative regulation of protein ubiquitination (GO:0031397) | 2.81309896 |
| 135 | spindle checkpoint (GO:0031577) | 2.79540152 |
| 136 | transcription from RNA polymerase I promoter (GO:0006360) | 2.77654978 |
| 137 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.77341751 |
| 138 | pseudouridine synthesis (GO:0001522) | 2.76543217 |
| 139 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.73008452 |
| 140 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.72602440 |
| 141 | rRNA modification (GO:0000154) | 2.72599999 |
| 142 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.71366645 |
| 143 | positive regulation of viral transcription (GO:0050434) | 2.71304690 |
| 144 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.70926131 |
| 145 | binding of sperm to zona pellucida (GO:0007339) | 2.70323914 |
| 146 | ATP synthesis coupled proton transport (GO:0015986) | 2.68783034 |
| 147 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.68783034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.97905765 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.79483063 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.78289861 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.74167400 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.62067159 |
| 6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.39927398 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.36406237 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.35634973 |
| 9 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.13510132 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.07922036 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.93045663 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.85966471 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.85741008 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.85205669 |
| 15 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.69960231 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.65476227 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.65365212 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.64329755 |
| 19 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.53709380 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.47867142 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.46654914 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.35463946 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.29245018 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.28282111 |
| 25 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.27418820 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.27263179 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.21332973 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14811848 |
| 29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.10689209 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.09600289 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00491649 |
| 32 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.98610508 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.97954595 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92512696 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.88878873 |
| 36 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87044187 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83639559 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82142322 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.80066190 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.79901702 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75214909 |
| 42 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.74251885 |
| 43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.71748179 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.71422501 |
| 45 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68994394 |
| 46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.67811095 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67248316 |
| 48 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67215991 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58465216 |
| 50 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54381306 |
| 51 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52331903 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.50700216 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44308442 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38039409 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.37994127 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36451360 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34114550 |
| 58 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.30815374 |
| 59 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27728438 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27321953 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26991861 |
| 62 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.25472783 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24687096 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23726155 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23660814 |
| 66 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23562142 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20658100 |
| 68 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19919679 |
| 69 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19516888 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17435741 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16879169 |
| 72 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15432659 |
| 73 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.14935894 |
| 74 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05855775 |
| 75 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04344518 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03410951 |
| 77 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02531109 |
| 78 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00711747 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00353234 |
| 80 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.99897594 |
| 81 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99258632 |
| 82 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98412524 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97628293 |
| 84 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.96060135 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94166843 |
| 86 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94092880 |
| 87 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91194159 |
| 88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89828009 |
| 89 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.86789469 |
| 90 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83927405 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83173352 |
| 92 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83029366 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81871328 |
| 94 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.77170667 |
| 95 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76992056 |
| 96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.75505682 |
| 97 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.74382602 |
| 98 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.73690691 |
| 99 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.73385189 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73290065 |
| 101 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.73222633 |
| 102 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72918827 |
| 103 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.71361325 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70963355 |
| 105 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.69525861 |
| 106 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.69465069 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68904838 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68734332 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 0.68491159 |
| 110 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.68149101 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.67808283 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 0.64991122 |
| 113 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.64718457 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.64384052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.48605091 |
| 2 | MP0003693_abnormal_embryo_hatching | 5.14215558 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.86538510 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.83093792 |
| 5 | MP0003077_abnormal_cell_cycle | 3.44508239 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.41066598 |
| 7 | MP0008007_abnormal_cellular_replicative | 3.35408310 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.95805927 |
| 9 | MP0008058_abnormal_DNA_repair | 2.57301511 |
| 10 | MP0003786_premature_aging | 2.51790711 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.46555225 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.43790107 |
| 13 | MP0003718_maternal_effect | 2.28402078 |
| 14 | MP0009697_abnormal_copulation | 2.22782912 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.13805195 |
| 16 | MP0001764_abnormal_homeostasis | 2.09951590 |
| 17 | MP0005410_abnormal_fertilization | 2.07557038 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.05240143 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.02963431 |
| 20 | MP0003186_abnormal_redox_activity | 2.02214746 |
| 21 | MP0000013_abnormal_adipose_tissue | 1.98596697 |
| 22 | MP0003123_paternal_imprinting | 1.92805667 |
| 23 | MP0002009_preneoplasia | 1.85846876 |
| 24 | MP0002163_abnormal_gland_morphology | 1.81628822 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.79937012 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.79717708 |
| 27 | MP0001929_abnormal_gametogenesis | 1.76573248 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.66945328 |
| 29 | MP0000490_abnormal_crypts_of | 1.65578148 |
| 30 | MP0001730_embryonic_growth_arrest | 1.53202886 |
| 31 | MP0002210_abnormal_sex_determination | 1.52639675 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.50136699 |
| 33 | MP0005671_abnormal_response_to | 1.44654445 |
| 34 | MP0004147_increased_porphyrin_level | 1.43375664 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.41641549 |
| 36 | MP0002796_impaired_skin_barrier | 1.40660772 |
| 37 | MP0001145_abnormal_male_reproductive | 1.38798528 |
| 38 | MP0005501_abnormal_skin_physiology | 1.36450688 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.36274144 |
| 40 | MP0001188_hyperpigmentation | 1.35999557 |
| 41 | MP0000313_abnormal_cell_death | 1.31851171 |
| 42 | MP0002019_abnormal_tumor_incidence | 1.30218832 |
| 43 | MP0001661_extended_life_span | 1.29223731 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.29112482 |
| 45 | MP0000653_abnormal_sex_gland | 1.28472064 |
| 46 | MP0009840_abnormal_foam_cell | 1.28458184 |
| 47 | MP0008260_abnormal_autophagy | 1.27575935 |
| 48 | MP0006035_abnormal_mitochondrial_morpho | 1.26900978 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.26130514 |
| 50 | MP0004381_abnormal_hair_follicle | 1.22935355 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.21227269 |
| 52 | MP0002132_abnormal_respiratory_system | 1.19602191 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.19314066 |
| 54 | MP0000858_altered_metastatic_potential | 1.17725812 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.13688603 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.13284629 |
| 57 | MP0002722_abnormal_immune_system | 1.12282250 |
| 58 | MP0003698_abnormal_male_reproductive | 1.11589936 |
| 59 | MP0002398_abnormal_bone_marrow | 1.11492447 |
| 60 | MP0002006_tumorigenesis | 1.09029214 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.08349592 |
| 62 | MP0001727_abnormal_embryo_implantation | 1.08079776 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.07740866 |
| 64 | MP0005451_abnormal_body_composition | 1.05596251 |
| 65 | MP0002080_prenatal_lethality | 1.04086452 |
| 66 | MP0005408_hypopigmentation | 0.98540001 |
| 67 | MP0001293_anophthalmia | 0.97588513 |
| 68 | MP0000427_abnormal_hair_cycle | 0.96882721 |
| 69 | MP0000647_abnormal_sebaceous_gland | 0.94796445 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 0.93584288 |
| 71 | MP0000685_abnormal_immune_system | 0.92367306 |
| 72 | MP0005266_abnormal_metabolism | 0.91724267 |
| 73 | MP0002095_abnormal_skin_pigmentation | 0.91482920 |
| 74 | MP0004233_abnormal_muscle_weight | 0.90535700 |
| 75 | MP0002429_abnormal_blood_cell | 0.90534196 |
| 76 | MP0003011_delayed_dark_adaptation | 0.89548790 |
| 77 | MP0001697_abnormal_embryo_size | 0.89285330 |
| 78 | MP0005310_abnormal_salivary_gland | 0.89260118 |
| 79 | MP0005380_embryogenesis_phenotype | 0.88557082 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.88557082 |
| 81 | MP0001119_abnormal_female_reproductive | 0.88401587 |
| 82 | MP0000358_abnormal_cell_content/ | 0.85631354 |
| 83 | MP0001873_stomach_inflammation | 0.85241069 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.85235498 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.85205491 |
| 86 | MP0003866_abnormal_defecation | 0.84926385 |
| 87 | MP0003646_muscle_fatigue | 0.83985131 |
| 88 | MP0000716_abnormal_immune_system | 0.83561442 |
| 89 | MP0004197_abnormal_fetal_growth/weight/ | 0.81890605 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.81195969 |
| 91 | MP0005647_abnormal_sex_gland | 0.81157183 |
| 92 | MP0002084_abnormal_developmental_patter | 0.81035047 |
| 93 | MP0010307_abnormal_tumor_latency | 0.80957427 |
| 94 | MP0005085_abnormal_gallbladder_physiolo | 0.78653558 |
| 95 | MP0002086_abnormal_extraembryonic_tissu | 0.78387659 |
| 96 | MP0001191_abnormal_skin_condition | 0.77112252 |
| 97 | MP0001243_abnormal_dermal_layer | 0.76261938 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.76201353 |
| 99 | MP0003941_abnormal_skin_development | 0.75049511 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.74670647 |
| 101 | MP0005395_other_phenotype | 0.74354128 |
| 102 | MP0001853_heart_inflammation | 0.74141110 |
| 103 | MP0005384_cellular_phenotype | 0.73944667 |
| 104 | MP0002161_abnormal_fertility/fecundity | 0.73763419 |
| 105 | MP0003984_embryonic_growth_retardation | 0.73683255 |
| 106 | MP0003699_abnormal_female_reproductive | 0.72850190 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.72833116 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.72537551 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.71372247 |
| 110 | MP0002088_abnormal_embryonic_growth/wei | 0.70513192 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 0.70409235 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.70149758 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.69004805 |
| 114 | MP0001800_abnormal_humoral_immune | 0.68881836 |
| 115 | MP0009672_abnormal_birth_weight | 0.68129751 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.67758438 |
| 117 | MP0002420_abnormal_adaptive_immunity | 0.67722849 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.67632169 |
| 119 | MP0005397_hematopoietic_system_phenotyp | 0.67632169 |
| 120 | MP0003436_decreased_susceptibility_to | 0.67487085 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.67134280 |
| 122 | MP0009379_abnormal_foot_pigmentation | 0.67062625 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.67055819 |
| 124 | MP0001819_abnormal_immune_cell | 0.66070292 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64776554 |
| 126 | MP0005365_abnormal_bile_salt | 0.62936322 |
| 127 | MP0008995_early_reproductive_senescence | 0.62070969 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.62011712 |
| 129 | MP0002723_abnormal_immune_serum | 0.61921208 |
| 130 | MP0000613_abnormal_salivary_gland | 0.61867335 |
| 131 | MP0000598_abnormal_liver_morphology | 0.61780867 |
| 132 | MP0002405_respiratory_system_inflammati | 0.61648880 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.60342286 |
| 134 | MP0002090_abnormal_vision | 0.60329329 |
| 135 | MP0000609_abnormal_liver_physiology | 0.59959954 |
| 136 | MP0002085_abnormal_embryonic_tissue | 0.59526492 |
| 137 | MP0000003_abnormal_adipose_tissue | 0.59056847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 11 pairs of ribs (HP:0000878) | 4.78421694 |
| 2 | Hepatocellular necrosis (HP:0001404) | 4.19276738 |
| 3 | Reticulocytopenia (HP:0001896) | 3.92676668 |
| 4 | Hepatic necrosis (HP:0002605) | 3.89702019 |
| 5 | Meckel diverticulum (HP:0002245) | 3.86181965 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 3.81347481 |
| 7 | Abnormality of the ileum (HP:0001549) | 3.64287147 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.64217623 |
| 9 | Birth length less than 3rd percentile (HP:0003561) | 3.63798789 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.60868430 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.47824242 |
| 12 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.46046446 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.35277012 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 3.31762142 |
| 15 | Acute encephalopathy (HP:0006846) | 3.20727737 |
| 16 | Increased CSF lactate (HP:0002490) | 3.19868272 |
| 17 | Microretrognathia (HP:0000308) | 3.04791191 |
| 18 | Selective tooth agenesis (HP:0001592) | 3.03868054 |
| 19 | Duodenal stenosis (HP:0100867) | 3.01357560 |
| 20 | Small intestinal stenosis (HP:0012848) | 3.01357560 |
| 21 | Agammaglobulinemia (HP:0004432) | 2.97639385 |
| 22 | Pancytopenia (HP:0001876) | 2.97107411 |
| 23 | Macrocytic anemia (HP:0001972) | 2.91722217 |
| 24 | Volvulus (HP:0002580) | 2.89001995 |
| 25 | Myelodysplasia (HP:0002863) | 2.82995162 |
| 26 | Chromsome breakage (HP:0040012) | 2.79989405 |
| 27 | Progressive macrocephaly (HP:0004481) | 2.78586315 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.76417527 |
| 29 | Oral leukoplakia (HP:0002745) | 2.72611522 |
| 30 | Abnormality of glycolysis (HP:0004366) | 2.72286784 |
| 31 | Increased serum pyruvate (HP:0003542) | 2.72286784 |
| 32 | Secondary amenorrhea (HP:0000869) | 2.71921695 |
| 33 | Breast hypoplasia (HP:0003187) | 2.71665745 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70744554 |
| 35 | Increased serum lactate (HP:0002151) | 2.66236644 |
| 36 | CNS demyelination (HP:0007305) | 2.66190184 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63436727 |
| 38 | Cholecystitis (HP:0001082) | 2.63256049 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.63256049 |
| 40 | Microvesicular hepatic steatosis (HP:0001414) | 2.61972622 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.55785469 |
| 42 | Entropion (HP:0000621) | 2.54214961 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.53876386 |
| 44 | Cerebral edema (HP:0002181) | 2.53750373 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53435833 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53435833 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.51683568 |
| 48 | Abnormality of the anterior horn cell (HP:0006802) | 2.51560157 |
| 49 | Degeneration of anterior horn cells (HP:0002398) | 2.51560157 |
| 50 | B lymphocytopenia (HP:0010976) | 2.50345350 |
| 51 | Abnormality of the duodenum (HP:0002246) | 2.49810590 |
| 52 | Clubbing of toes (HP:0100760) | 2.49328018 |
| 53 | Impulsivity (HP:0100710) | 2.46783991 |
| 54 | Pallor (HP:0000980) | 2.46029042 |
| 55 | Ureteral duplication (HP:0000073) | 2.44410720 |
| 56 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.40841285 |
| 57 | Cerebral hypomyelination (HP:0006808) | 2.39622814 |
| 58 | Severe combined immunodeficiency (HP:0004430) | 2.39147047 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39120811 |
| 60 | Missing ribs (HP:0000921) | 2.39024031 |
| 61 | Ependymoma (HP:0002888) | 2.37784520 |
| 62 | Abnormality of DNA repair (HP:0003254) | 2.34770429 |
| 63 | Recurrent bacterial skin infections (HP:0005406) | 2.33784904 |
| 64 | Lactic acidosis (HP:0003128) | 2.32200076 |
| 65 | Sparse eyelashes (HP:0000653) | 2.32031213 |
| 66 | Premature ovarian failure (HP:0008209) | 2.30947223 |
| 67 | Abnormal lung lobation (HP:0002101) | 2.29189153 |
| 68 | Emotional lability (HP:0000712) | 2.28009553 |
| 69 | Abnormality of the labia minora (HP:0012880) | 2.27105797 |
| 70 | Aplastic anemia (HP:0001915) | 2.26921944 |
| 71 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26899638 |
| 72 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25833550 |
| 73 | Testicular atrophy (HP:0000029) | 2.25332026 |
| 74 | Abnormal spermatogenesis (HP:0008669) | 2.25278082 |
| 75 | Gout (HP:0001997) | 2.24027688 |
| 76 | Abnormality of B cell number (HP:0010975) | 2.24010010 |
| 77 | Hyperglycinuria (HP:0003108) | 2.23330590 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20862596 |
| 79 | Cellular immunodeficiency (HP:0005374) | 2.19866196 |
| 80 | Multiple enchondromatosis (HP:0005701) | 2.18955626 |
| 81 | Dry hair (HP:0011359) | 2.18910283 |
| 82 | 3-Methylglutaconic aciduria (HP:0003535) | 2.18150212 |
| 83 | Colon cancer (HP:0003003) | 2.17995183 |
| 84 | Exertional dyspnea (HP:0002875) | 2.15256773 |
| 85 | Abnormal trabecular bone morphology (HP:0100671) | 2.15025043 |
| 86 | Rhabdomyosarcoma (HP:0002859) | 2.14755612 |
| 87 | Abnormality of the carotid arteries (HP:0005344) | 2.14603383 |
| 88 | Horseshoe kidney (HP:0000085) | 2.12250350 |
| 89 | Poikiloderma (HP:0001029) | 2.12082384 |
| 90 | Infertility (HP:0000789) | 2.11545125 |
| 91 | Poor head control (HP:0002421) | 2.10574577 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 2.09870291 |
| 93 | Gonadotropin excess (HP:0000837) | 2.08161516 |
| 94 | Bone marrow hypocellularity (HP:0005528) | 2.06265859 |
| 95 | Villous atrophy (HP:0011473) | 2.05438736 |
| 96 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.05438736 |
| 97 | Respiratory failure (HP:0002878) | 2.05290536 |
| 98 | Lethargy (HP:0001254) | 2.05172658 |
| 99 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.01736899 |
| 100 | Neutropenia (HP:0001875) | 1.99784357 |
| 101 | Agnosia (HP:0010524) | 1.99154507 |
| 102 | Encephalitis (HP:0002383) | 1.99142499 |
| 103 | Chronic bronchitis (HP:0004469) | 1.98873760 |
| 104 | Prominent metopic ridge (HP:0005487) | 1.98539959 |
| 105 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97421604 |
| 106 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97421604 |
| 107 | Megaloblastic anemia (HP:0001889) | 1.95309793 |
| 108 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.94597586 |
| 109 | Exercise intolerance (HP:0003546) | 1.92921646 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 1.92474063 |
| 111 | Respiratory difficulties (HP:0002880) | 1.91760756 |
| 112 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91668896 |
| 113 | Abnormality of lateral ventricle (HP:0030047) | 1.91460933 |
| 114 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.88396966 |
| 115 | Absent/shortened dynein arms (HP:0200106) | 1.88396966 |
| 116 | Abnormal protein glycosylation (HP:0012346) | 1.88373814 |
| 117 | Abnormal glycosylation (HP:0012345) | 1.88373814 |
| 118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.88373814 |
| 119 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.88373814 |
| 120 | Duplicated collecting system (HP:0000081) | 1.88290776 |
| 121 | Abnormality of the preputium (HP:0100587) | 1.88082867 |
| 122 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.86103314 |
| 123 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.86013298 |
| 124 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.84809602 |
| 125 | Hypoplasia of the radius (HP:0002984) | 1.84708110 |
| 126 | Oligodactyly (hands) (HP:0001180) | 1.83352457 |
| 127 | Abnormality of chromosome stability (HP:0003220) | 1.82801609 |
| 128 | Recurrent abscess formation (HP:0002722) | 1.82113906 |
| 129 | Absent thumb (HP:0009777) | 1.81835798 |
| 130 | Glioma (HP:0009733) | 1.80735148 |
| 131 | Facial cleft (HP:0002006) | 1.80409665 |
| 132 | Sloping forehead (HP:0000340) | 1.79097724 |
| 133 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.78676302 |
| 134 | Reduced antithrombin III activity (HP:0001976) | 1.78324541 |
| 135 | Carpal bone hypoplasia (HP:0001498) | 1.77575607 |
| 136 | CNS hypomyelination (HP:0003429) | 1.77399980 |
| 137 | Hypoproteinemia (HP:0003075) | 1.77127976 |
| 138 | Cleft eyelid (HP:0000625) | 1.76919381 |
| 139 | Recurrent viral infections (HP:0004429) | 1.76465243 |
| 140 | Increased intramyocellular lipid droplets (HP:0012240) | 1.75876730 |
| 141 | Increased muscle lipid content (HP:0009058) | 1.75791229 |
| 142 | Astrocytoma (HP:0009592) | 1.75264768 |
| 143 | Abnormality of the astrocytes (HP:0100707) | 1.75264768 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75245934 |
| 145 | Abnormality of glycine metabolism (HP:0010895) | 1.75245934 |
| 146 | Hypokinesia (HP:0002375) | 1.73811802 |
| 147 | Progressive muscle weakness (HP:0003323) | 1.73629168 |
| 148 | Ectopic kidney (HP:0000086) | 1.73221958 |
| 149 | Recurrent cutaneous fungal infections (HP:0011370) | 1.71106387 |
| 150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.71106387 |
| 151 | Squamous cell carcinoma (HP:0002860) | 1.70512537 |
| 152 | Cafe-au-lait spot (HP:0000957) | 1.70041380 |
| 153 | Sensory axonal neuropathy (HP:0003390) | 1.68746698 |
| 154 | Autoimmune hemolytic anemia (HP:0001890) | 1.68065863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.13143548 |
| 2 | EIF2AK1 | 4.67531493 |
| 3 | WEE1 | 3.44469780 |
| 4 | PBK | 3.19510149 |
| 5 | STK16 | 2.98278260 |
| 6 | CDC7 | 2.93352278 |
| 7 | BMPR1B | 2.76839167 |
| 8 | VRK2 | 2.66012473 |
| 9 | DYRK3 | 2.60841150 |
| 10 | TRIM28 | 2.44411982 |
| 11 | EIF2AK3 | 2.31180348 |
| 12 | PDK3 | 2.31067668 |
| 13 | PDK4 | 2.31067668 |
| 14 | NME2 | 2.26179499 |
| 15 | RIPK1 | 2.22534075 |
| 16 | PLK4 | 2.14041498 |
| 17 | TSSK6 | 2.11221118 |
| 18 | NUAK1 | 2.05121881 |
| 19 | TLK1 | 2.00907529 |
| 20 | VRK1 | 1.83213518 |
| 21 | NEK2 | 1.79972064 |
| 22 | TTK | 1.79560427 |
| 23 | BRSK2 | 1.76601473 |
| 24 | PLK1 | 1.65823357 |
| 25 | ACVR1B | 1.65162149 |
| 26 | ATR | 1.59170645 |
| 27 | STK10 | 1.56069752 |
| 28 | PASK | 1.54645527 |
| 29 | NEK1 | 1.54290915 |
| 30 | TESK1 | 1.42228592 |
| 31 | TGFBR1 | 1.39638860 |
| 32 | ARAF | 1.39420778 |
| 33 | BRAF | 1.37603528 |
| 34 | PDK2 | 1.36874092 |
| 35 | MAP4K2 | 1.35607507 |
| 36 | MST4 | 1.33071454 |
| 37 | RPS6KA4 | 1.32464003 |
| 38 | SRPK1 | 1.31411711 |
| 39 | PIM2 | 1.31298715 |
| 40 | AURKB | 1.29162778 |
| 41 | IRAK2 | 1.23484887 |
| 42 | BRSK1 | 1.22631935 |
| 43 | PLK3 | 1.21484763 |
| 44 | AURKA | 1.20929180 |
| 45 | PNCK | 1.20101421 |
| 46 | BCKDK | 1.12813742 |
| 47 | MET | 1.12804973 |
| 48 | CDK4 | 1.11408521 |
| 49 | CDK7 | 1.10959256 |
| 50 | EIF2AK2 | 1.10842253 |
| 51 | SCYL2 | 1.10797732 |
| 52 | MKNK1 | 1.07332438 |
| 53 | ZAK | 1.06837728 |
| 54 | CDK9 | 1.04868562 |
| 55 | TESK2 | 0.98845429 |
| 56 | MAP4K1 | 0.96164528 |
| 57 | MUSK | 0.92650490 |
| 58 | KIT | 0.92394005 |
| 59 | FLT3 | 0.91273717 |
| 60 | SIK3 | 0.90466847 |
| 61 | NME1 | 0.89782342 |
| 62 | CDK8 | 0.88995620 |
| 63 | CHEK1 | 0.87380035 |
| 64 | BCR | 0.87290803 |
| 65 | PIM1 | 0.85747438 |
| 66 | CHEK2 | 0.84375626 |
| 67 | WNK3 | 0.83894941 |
| 68 | MAP3K8 | 0.82108205 |
| 69 | MKNK2 | 0.81269704 |
| 70 | EPHA2 | 0.81187853 |
| 71 | TEC | 0.78058992 |
| 72 | MST1R | 0.76951694 |
| 73 | CSNK2A2 | 0.76279285 |
| 74 | ERBB3 | 0.75922781 |
| 75 | CSNK2A1 | 0.73201004 |
| 76 | RPS6KB2 | 0.73000117 |
| 77 | CCNB1 | 0.72903540 |
| 78 | KDR | 0.72571748 |
| 79 | CLK1 | 0.72508252 |
| 80 | STK4 | 0.72140225 |
| 81 | PRKCI | 0.71518286 |
| 82 | STK38L | 0.70182931 |
| 83 | ZAP70 | 0.69905889 |
| 84 | IRAK3 | 0.65505289 |
| 85 | ILK | 0.64382030 |
| 86 | LRRK2 | 0.60804902 |
| 87 | JAK3 | 0.59798982 |
| 88 | IKBKB | 0.59105951 |
| 89 | PAK1 | 0.57432770 |
| 90 | MOS | 0.57430697 |
| 91 | ATM | 0.54520157 |
| 92 | STK3 | 0.53604819 |
| 93 | CDK19 | 0.51744290 |
| 94 | BMPR2 | 0.51350642 |
| 95 | SMG1 | 0.50056214 |
| 96 | DAPK1 | 0.49800579 |
| 97 | CSNK1G1 | 0.49686583 |
| 98 | CDK2 | 0.48177175 |
| 99 | TXK | 0.48110511 |
| 100 | TAOK3 | 0.46338451 |
| 101 | PLK2 | 0.46132652 |
| 102 | ABL2 | 0.44941103 |
| 103 | MAP3K12 | 0.44871017 |
| 104 | GRK7 | 0.44059503 |
| 105 | MARK3 | 0.43869940 |
| 106 | PAK4 | 0.43867841 |
| 107 | TYK2 | 0.41001306 |
| 108 | SYK | 0.40973685 |
| 109 | DYRK2 | 0.40857377 |
| 110 | TAF1 | 0.40407778 |
| 111 | MAPK11 | 0.39881112 |
| 112 | RAF1 | 0.39750127 |
| 113 | MAPKAPK3 | 0.38916019 |
| 114 | CSNK1E | 0.37847131 |
| 115 | MAP3K9 | 0.36646247 |
| 116 | GRK1 | 0.36293860 |
| 117 | ALK | 0.36290127 |
| 118 | CSF1R | 0.35951848 |
| 119 | CDK1 | 0.35317291 |
| 120 | PIK3CG | 0.35158930 |
| 121 | CSNK1G3 | 0.35116888 |
| 122 | MAP2K7 | 0.34773561 |
| 123 | MELK | 0.34743526 |
| 124 | TNIK | 0.34576552 |
| 125 | CHUK | 0.34561363 |
| 126 | RPS6KA5 | 0.34071384 |
| 127 | STK24 | 0.32315986 |
| 128 | MAP3K5 | 0.30314850 |
| 129 | IRAK4 | 0.30144150 |
| 130 | MAP3K6 | 0.29728228 |
| 131 | LCK | 0.29067760 |
| 132 | LYN | 0.27510129 |
| 133 | MAP3K11 | 0.26797974 |
| 134 | MAPKAPK2 | 0.26716600 |
| 135 | MYLK | 0.26417255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.13337539 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 4.11509446 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.78578793 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.49399986 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.06050833 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.94256097 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.68718001 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.66094855 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.56057043 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.55836241 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.44127596 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.41942363 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.36685509 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.35111516 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.16709521 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.16011434 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 2.14346334 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 2.11192153 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.93224131 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.83915854 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74185171 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.72575166 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68990495 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.55509527 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.53697395 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.51646870 |
| 27 | Purine metabolism_Homo sapiens_hsa00230 | 1.46847200 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44579252 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42734424 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38577875 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36718527 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30507101 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23709527 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23385531 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20823534 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16285181 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09048694 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08786428 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04813564 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03493118 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94928359 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89582350 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88590317 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86279515 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76728805 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.76696938 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75597996 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74727252 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73714537 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73637091 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72370189 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72223308 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69698698 |
| 54 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68068120 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64879544 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63160077 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62689412 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61770695 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59558429 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57033834 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56600387 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56452574 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55514998 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53637120 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49878668 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49542223 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48699895 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47210584 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45952977 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44874951 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44017248 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43709719 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43544926 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43459800 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43430692 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.42399472 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41921322 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41400727 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41311028 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41201942 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40343739 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37929955 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.37499387 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36505971 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36104365 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35991527 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35389760 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34991301 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34105039 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33312225 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33280594 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32239813 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31432480 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30563784 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30488464 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.28800000 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.28603637 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28026105 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.26229485 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.26173921 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25104107 |
| 102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24248484 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.23442999 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23047066 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.22322982 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20875236 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20821682 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.20569001 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20555337 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20185087 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20031698 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20021764 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18424677 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18349202 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.17926657 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.17168394 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.17153908 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16958928 |
| 119 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.16779260 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.16511273 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15992074 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15282097 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.15083366 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14600460 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.13758990 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13128947 |

